PBMs' trade group slams FTC's insulin 'greed' lawsuit
The PBMs say out-of-pocket insulin costs have fallen sharply since 2019. The Pharmaceutical Care Management Association, pharmacy benefit managers' trade group, says the Federal Trade Commission's attack on PBMs' role in negotiating insulin prices is the result of a biased, anti-industry investigation.